Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Hesping

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Microbiology|April 16, 2022
A conserved malaria parasite protein required for maintenance of sporozoite cell shape and transmissionJohannes T Dessens, Eva Hesping
Molecular Microbiology|January 15, 2024
Whole-genome CRISPR screens to understand Apicomplexan-host interactionsEva Hesping, Justin A Boddey
Plos Genetics|May 18, 2026
Cas9-expressing HC-04 hepatocytes facilitate CRISPR-based analysis of Plasmodium falciparum sporozoite-host interactionsLisa H Verzier, Eva Hesping, Marcel Doerflinger, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 6, 2020
An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylationEva Hesping, Tina S Skinner-Adams, Gillian M Fisher, et al.
European Journal of Medicinal Chemistry|January 15, 2026
Improved quantitative structure-activity relationship (QSAR) models to predict the activity of hydroxamic acids as HDAC inhibitors against malaria parasitesWisam A Dawood, Jacinta R Macdonald, Tina S Skinner-Adams, et al.
European Journal of Medicinal Chemistry|December 28, 2020
Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activityMarcel K W Mackwitz, Eva Hesping, Korina Eribez, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 24, 2021
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in miceMing Jang Chua, Jiahui Tng, Eva Hesping, et al.
European Journal of Medicinal Chemistry|September 25, 2018
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasitesDaniela Diedrich, Katharina Stenzel, Eva Hesping, et al.
Chemmedchem|January 22, 2019
Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial ActivityMarcel K W Mackwitz, Eva Hesping, Yevgeniya Antonova-Koch, et al.
ACS Infectious Diseases|January 5, 2022
QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria ParasitesEva Hesping, Ming Jang Chua, Marc Pflieger, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Microbiology|April 16, 2022
A conserved malaria parasite protein required for maintenance of sporozoite cell shape and transmissionJohannes T Dessens, Eva Hesping
Molecular Microbiology|January 15, 2024
Whole-genome CRISPR screens to understand Apicomplexan-host interactionsEva Hesping, Justin A Boddey
Plos Genetics|May 18, 2026
Cas9-expressing HC-04 hepatocytes facilitate CRISPR-based analysis of Plasmodium falciparum sporozoite-host interactionsLisa H Verzier, Eva Hesping, Marcel Doerflinger, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 6, 2020
An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylationEva Hesping, Tina S Skinner-Adams, Gillian M Fisher, et al.
European Journal of Medicinal Chemistry|January 15, 2026
Improved quantitative structure-activity relationship (QSAR) models to predict the activity of hydroxamic acids as HDAC inhibitors against malaria parasitesWisam A Dawood, Jacinta R Macdonald, Tina S Skinner-Adams, et al.
European Journal of Medicinal Chemistry|December 28, 2020
Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activityMarcel K W Mackwitz, Eva Hesping, Korina Eribez, et al.
International Journal for Parasitology. Drugs and Drug Resistance|September 24, 2021
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in miceMing Jang Chua, Jiahui Tng, Eva Hesping, et al.
European Journal of Medicinal Chemistry|September 25, 2018
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasitesDaniela Diedrich, Katharina Stenzel, Eva Hesping, et al.
Chemmedchem|January 22, 2019
Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial ActivityMarcel K W Mackwitz, Eva Hesping, Yevgeniya Antonova-Koch, et al.
ACS Infectious Diseases|January 5, 2022
QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria ParasitesEva Hesping, Ming Jang Chua, Marc Pflieger, et al.
Pageof 2